Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
18 hedge funds and large institutions have $1.41M invested in Vaxart in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
53% more capital invested
Capital invested by funds: $919K → $1.41M (+$489K)
1.76% more ownership
Funds ownership: 6.88% → 8.64% (+1.8%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
14% less funds holding
Funds holding: 21 → 18 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$375K |
| 2 |
Renaissance Technologies
New York
|
+$121K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.9K |
| 4 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$3.81K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.67K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$37K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$35K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$7.08K |
| 4 |
QT
Quantamental Technologies
White Plains,
New York
|
-$4K |
| 5 |
TL
TowerView LLC
New York
|
-$3K |
VXRT Hedge Fund Activity: Q1 2019 in Review
18 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q1 2019, worth a combined $1.41M — up 53% from $919K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of VXRT and 3 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $375K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $37K sold.
- 18 institutional investors held Vaxart (VXRT) as of Q1 2019, down from 21 in Q4 2018.
- Funds reported $1.41M of Vaxart stock for Q1 2019, up 53% quarter-over-quarter.
- 3 funds opened new Vaxart positions in Q1 2019 and 6 closed out, a net change of -3 holders.
- The largest Vaxart buyer in Q1 2019 was Sabby Management, an estimated $375K added.
- The largest Vaxart seller in Q1 2019 was Susquehanna International Group, an estimated $37K sold.
Based on aggregated 13F filings for Q1 2019.